ICU MEDICAL INC (ICUI) Stock Fundamental Analysis
NASDAQ:ICUI - Nasdaq - US44930G1076 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to ICUI. ICUI was compared to 190 industry peers in the Health Care Equipment & Supplies industry. The financial health of ICUI is average, but there are quite some concerns on its profitability. ICUI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ICUI had positive earnings in the past year.
In the past year ICUI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ICUI reported negative net income in multiple years.
ICUI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
ICUI has a Return On Assets of -2.58%. This is in the better half of the industry: ICUI outperforms 66.49% of its industry peers.
The Return On Equity of ICUI (-5.42%) is better than 67.55% of its industry peers.
With a decent Return On Invested Capital value of 1.13%, ICUI is doing good in the industry, outperforming 67.55% of the companies in the same industry.
ICUI had an Average Return On Invested Capital over the past 3 years of 2.84%. This is significantly below the industry average of 8.19%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.58% | ||
| ROE | -5.42% | ||
| ROIC | 1.13% |
ROA(3y)1.05%
ROA(5y)2.81%
ROE(3y)0.48%
ROE(5y)2.91%
ROIC(3y)2.84%
ROIC(5y)5.09%
1.3 Margins
ICUI's Operating Margin of 2.30% is fine compared to the rest of the industry. ICUI outperforms 67.55% of its industry peers.
In the last couple of years the Operating Margin of ICUI has declined.
ICUI has a worse Gross Margin (32.87%) than 72.34% of its industry peers.
ICUI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 32.87% |
OM growth 3Y-34.03%
OM growth 5Y-25.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5Y-4.26%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICUI is destroying value.
Compared to 1 year ago, ICUI has more shares outstanding
The number of shares outstanding for ICUI has been increased compared to 5 years ago.
The debt/assets ratio for ICUI is higher compared to a year ago.
2.2 Solvency
ICUI has an Altman-Z score of 2.08. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
ICUI has a better Altman-Z score (2.08) than 60.64% of its industry peers.
The Debt to FCF ratio of ICUI is 10.01, which is on the high side as it means it would take ICUI, 10.01 years of fcf income to pay off all of its debts.
ICUI has a better Debt to FCF ratio (10.01) than 72.34% of its industry peers.
ICUI has a Debt/Equity ratio of 0.75. This is a neutral value indicating ICUI is somewhat dependend on debt financing.
The Debt to Equity ratio of ICUI (0.75) is worse than 72.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 10.01 | ||
| Altman-Z | 2.08 |
ROIC/WACC0.13
WACC8.62%
2.3 Liquidity
A Current Ratio of 2.29 indicates that ICUI has no problem at all paying its short term obligations.
ICUI has a Current ratio (2.29) which is comparable to the rest of the industry.
A Quick Ratio of 1.03 indicates that ICUI should not have too much problems paying its short term obligations.
ICUI has a worse Quick ratio (1.03) than 76.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.29 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
ICUI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.35%.
ICUI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.22% yearly.
ICUI shows a small growth in Revenue. In the last year, the Revenue has grown by 4.04%.
Measured over the past years, ICUI shows a quite strong growth in Revenue. The Revenue has been growing by 10.04% on average per year.
EPS 1Y (TTM)-16.35%
EPS 3Y-1.76%
EPS 5Y-5.22%
EPS Q2Q%1.27%
Revenue 1Y (TTM)4.04%
Revenue growth 3Y21.13%
Revenue growth 5Y10.04%
Sales Q2Q%7.78%
3.2 Future
The Earnings Per Share is expected to grow by 14.03% on average over the next years. This is quite good.
The Revenue is expected to grow by 1.29% on average over the next years.
EPS Next Y-15.48%
EPS Next 2Y3.72%
EPS Next 3Y8.82%
EPS Next 5Y14.03%
Revenue Next Year4.47%
Revenue Next 2Y2.39%
Revenue Next 3Y2.59%
Revenue Next 5Y1.29%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 27.69, the valuation of ICUI can be described as expensive.
Based on the Price/Earnings ratio, ICUI is valued a bit cheaper than the industry average as 76.06% of the companies are valued more expensively.
ICUI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.63.
With a Price/Forward Earnings ratio of 21.62, ICUI is valued on the expensive side.
ICUI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ICUI is cheaper than 78.19% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. ICUI is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.69 | ||
| Fwd PE | 21.62 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICUI indicates a somewhat cheap valuation: ICUI is cheaper than 78.72% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ICUI is valued cheaply inside the industry as 85.11% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.13 | ||
| EV/EBITDA | 19.02 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.72%
EPS Next 3Y8.82%
5. Dividend
5.1 Amount
No dividends for ICUI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
157.26
-5.89 (-3.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners98.32%
Inst Owner Change-0.36%
Ins Owners1.04%
Ins Owner Change-0.21%
Market Cap3.85B
Analysts81.82
Price Target213.95 (36.05%)
Short Float %3.23%
Short Ratio3.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.95%
Min EPS beat(2)24.67%
Max EPS beat(2)53.22%
EPS beat(4)4
Avg EPS beat(4)30.44%
Min EPS beat(4)14.78%
Max EPS beat(4)53.22%
EPS beat(8)8
Avg EPS beat(8)21.02%
EPS beat(12)11
Avg EPS beat(12)14.58%
EPS beat(16)15
Avg EPS beat(16)13.81%
Revenue beat(2)2
Avg Revenue beat(2)1.69%
Min Revenue beat(2)0.5%
Max Revenue beat(2)2.87%
Revenue beat(4)3
Avg Revenue beat(4)0.43%
Min Revenue beat(4)-1.9%
Max Revenue beat(4)2.87%
Revenue beat(8)3
Avg Revenue beat(8)-2.12%
Revenue beat(12)5
Avg Revenue beat(12)-1.2%
Revenue beat(16)9
Avg Revenue beat(16)0.23%
PT rev (1m)0%
PT rev (3m)18.91%
EPS NQ rev (1m)-0.2%
EPS NQ rev (3m)-5.3%
EPS NY rev (1m)0%
EPS NY rev (3m)7.29%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.69 | ||
| Fwd PE | 21.62 | ||
| P/S | 1.65 | ||
| P/FCF | 24.13 | ||
| P/OCF | 15.09 | ||
| P/B | 1.88 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.02 |
EPS(TTM)5.68
EY3.61%
EPS(NY)7.27
Fwd EY4.62%
FCF(TTM)6.52
FCFY4.14%
OCF(TTM)10.42
OCFY6.63%
SpS95.59
BVpS83.68
TBVpS-8.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.58% | ||
| ROE | -5.42% | ||
| ROCE | 1.43% | ||
| ROIC | 1.13% | ||
| ROICexc | 1.24% | ||
| ROICexgc | 3.61% | ||
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 32.87% | ||
| FCFM | 6.82% |
ROA(3y)1.05%
ROA(5y)2.81%
ROE(3y)0.48%
ROE(5y)2.91%
ROIC(3y)2.84%
ROIC(5y)5.09%
ROICexc(3y)4.01%
ROICexc(5y)6.78%
ROICexgc(3y)6.07%
ROICexgc(5y)9.15%
ROCE(3y)3.59%
ROCE(5y)6.44%
ROICexcg growth 3Y-28.58%
ROICexcg growth 5Y-25.74%
ROICexc growth 3Y-45.47%
ROICexc growth 5Y-37.56%
OM growth 3Y-34.03%
OM growth 5Y-25.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5Y-4.26%
F-Score4
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 10.01 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 42.73% | ||
| Cap/Sales | 4.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.92% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.29 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.08 |
F-Score4
WACC8.62%
ROIC/WACC0.13
Cap/Depr(3y)57.9%
Cap/Depr(5y)85.76%
Cap/Sales(3y)4.89%
Cap/Sales(5y)6.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.35%
EPS 3Y-1.76%
EPS 5Y-5.22%
EPS Q2Q%1.27%
EPS Next Y-15.48%
EPS Next 2Y3.72%
EPS Next 3Y8.82%
EPS Next 5Y14.03%
Revenue 1Y (TTM)4.04%
Revenue growth 3Y21.13%
Revenue growth 5Y10.04%
Sales Q2Q%7.78%
Revenue Next Year4.47%
Revenue Next 2Y2.39%
Revenue Next 3Y2.59%
Revenue Next 5Y1.29%
EBIT growth 1Y-28.24%
EBIT growth 3Y-20.09%
EBIT growth 5Y-18.37%
EBIT Next Year25.87%
EBIT Next 3Y15.33%
EBIT Next 5Y11.53%
FCF growth 1Y305.62%
FCF growth 3Y-16.01%
FCF growth 5Y4.08%
OCF growth 1Y1049.29%
OCF growth 3Y-9.31%
OCF growth 5Y0.74%